News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
GENESIS Biomed impulsa la creación de PolyFIL Diagnostics
GENESIS Biomed drives the creation of PolyFIL Diagnostics, a spin-off from Hospital Universitario La Paz that detects polyps and colorectal cancer through blood-based liquid biopsy
Healthcare · Access to innovation · In vitro diagnostics
The technology, developed at the Health Research Institute of Hospital Universitario La Paz (IdiPAZ…
Partners - GENESIS Biomed
Asís Ariznavarreta, nuevo Director de la Unidad de Acceso al Mercado y al Paciente de Outcomes’10 en España
Asís Ariznavarreta is named Leader of the Market & Patient Access Unit at Outcomes’10 in Spain (a PLG company)
Healthcare · Access to innovation · Innovative drugs
His new role leading the Market & Patient Access unit at Outcomes’10 in Spain reinforces…
Partners - ProductLife Group
Proyecto Lignin2value
Natac receives €590,000 to industrialize botanical ingredients and lignin-rich precursors for nutraceutical and cosmetic applications
Financing
The company is coordinating one of the business cases for the European I3-LIGNIN2VALUE project,…
Partners - Natac Group
Sede de ORYZON
ORYZON receives European Medicines Agency approval to initiate the HOPE-2 Phase II study of vafidemstat for the treatment of Phelan-McDermid Syndrome (PMS)
Healthcare · Rare diseases · Innovative drugs
PMS is a severely disabling genetic disorder related to autism.
Partners - Oryzon Genomics
personas senior confrontan la enfermedad del alzheimer
Biomarkers and artificial intelligence open new avenues for anticipating Alzheimer’s progression
Healthcare · Drug discovery · Personalized medicine
In Spain, nearly one million people were living with dementia in 2025, according to estimates from…
Partners - ADmit Therapeutics
Imagen de You trusted CRO partner - Biobide
Biobide Expands Ecotoxicology Portfolio to a Full-Spectrum, GLP-Certified Testing Platform Across All Trophic Levels
Agrifood · Animal health · Industrial biotechnology
Biobide has grown its ecotoxicology service line into a more comprehensive GLP-certified testing…
Partners - Biobide
Image mRNA vaccines for the future of medicine
mRNA vaccines for the future of medicine
Healthcare · Coronavirus · Innovative drugs
The COVID-19 pandemic transformed mRNA technology into a large-scale clinical platform and…
Partners - GENESIS Biomed
EDIFICIO ORYZON
ORYZON to participate in upcoming events in September and October
Healthcare · Innovative drugs · International
Oryzon Genomics will participate in several international investment and capital markets events in…
Partners - Oryzon Genomics
CONNECTATherapeutics_JordiFabrega_JosepProus
CONNECTA Therapeutics Announces Financing to Advance Clinical Development of Fragile X Syndrome Program
Healthcare · Rare diseases · Innovative drugs
€3.1 million financing led by new investor Clave Capital, with participation from existing…
Partners - CONNECTA THERAPEUTICS